Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Department of Intensive Care, Randers Hospital, Randers, Denmark.
Intensive Care Med. 2016 Nov;42(11):1695-1705. doi: 10.1007/s00134-016-4500-7. Epub 2016 Sep 30.
We assessed the effects of a protocol restricting resuscitation fluid vs. a standard care protocol after initial resuscitation in intensive care unit (ICU) patients with septic shock.
We randomised 151 adult patients with septic shock who had received initial fluid resuscitation in nine Scandinavian ICUs. In the fluid restriction group fluid boluses were permitted only if signs of severe hypoperfusion occurred, while in the standard care group fluid boluses were permitted as long as circulation continued to improve.
The co-primary outcome measures, resuscitation fluid volumes at day 5 and during ICU stay, were lower in the fluid restriction group than in the standard care group [mean differences -1.2 L (95 % confidence interval -2.0 to -0.4); p < 0.001 and -1.4 L (-2.4 to -0.4) respectively; p < 0.001]. Neither total fluid inputs and balances nor serious adverse reactions differed statistically significantly between the groups. Major protocol violations occurred in 27/75 patients in the fluid restriction group. Ischaemic events occurred in 3/75 in the fluid restriction group vs. 9/76 in the standard care group (odds ratio 0.32; 0.08-1.27; p = 0.11), worsening of acute kidney injury in 27/73 vs. 39/72 (0.46; 0.23-0.92; p = 0.03), and death by 90 days in 25/75 vs. 31/76 (0.71; 0.36-1.40; p = 0.32).
A protocol restricting resuscitation fluid successfully reduced volumes of resuscitation fluid compared with a standard care protocol in adult ICU patients with septic shock. The patient-centred outcomes all pointed towards benefit with fluid restriction, but our trial was not powered to show differences in these exploratory outcomes.
NCT02079402.
我们评估了在接受初始复苏后,限制复苏液与标准治疗方案相比,对重症监护病房(ICU)中伴有脓毒性休克的患者的影响。
我们将来自 9 家斯堪的纳维亚 ICU 的 151 名成年脓毒性休克患者随机分为限制液体复苏组和标准治疗组。在限制液体复苏组中,只有在出现严重低灌注迹象时才允许进行液体冲击治疗,而在标准治疗组中,只要循环持续改善就允许进行液体冲击治疗。
主要的转归测量指标是第 5 天和 ICU 住院期间的复苏液量,限制液体复苏组的复苏液量明显低于标准治疗组[平均差异-1.2 L(95%置信区间-2.0 至-0.4);p<0.001和-1.4 L(-2.4 至-0.4);p<0.001]。两组之间总液体输入量和平衡量以及严重不良反应均无统计学差异。在限制液体复苏组中,有 27/75 名患者发生了主要方案违反。在限制液体复苏组中,缺血性事件的发生率为 3/75 例,而标准治疗组为 9/76 例(比值比 0.32;0.08-1.27;p=0.11),急性肾损伤恶化的发生率为 27/73 例,标准治疗组为 39/72 例(0.46;0.23-0.92;p=0.03),90 天死亡率为 25/75 例,标准治疗组为 31/76 例(0.71;0.36-1.40;p=0.32)。
与标准治疗方案相比,限制复苏液的方案成功减少了成年 ICU 中伴有脓毒性休克患者的复苏液量。以患者为中心的结局都指向了限制液体的益处,但我们的试验没有足够的能力显示这些探索性结局的差异。
NCT02079402。